ENVY INTERNATIONAL are sole representative in India for BIOCORE INC., USA

BIOCORE is a leading wound care management product company established in 1988 for manufacturing Collagen products. The technology behind these FDA approved products, was developed in house by Dr. MANOJ JAIN and has been accepted in US as Wound Care Technology of the future. Mrs. Neelam Bafna, M.D., Envy International, was instrumental in bringing these products into India.

Biocore's Collagen based products are excellent when used on open wounds, Diabetic wounds, Chronic leg ulcers and pressure sores, burns urological & gynecological surgery, reconstructive surgery and abdominal surgeries. They provide a substantial reduction in the healing time.

Doctors are acquainted with the frustration & anguish associated with diabetic ulcers, venous stasis wounds and pressure ulcers which do not heal. Current treatment methods only result in closure of 43% of these types of chronic wounds, the remainder do not heal and the result is catastrophic. Quality of life suffers, many patients suffer multiple amputations and often death. It does not have to continue this way.

Biocore's  proprietary and unmatched technology allows the delivery to the wound site of properly assembled collagen molecules with self-assembling capabilities and organized into aggregates which are specific to human skin. What does this mean? Patients heal. Results indicate that Biocore's Kollagen technology closes 95% of chronic wounds. BioCore's SkinTemp and Medifil products deliver to the wound the body's one common  denominator to its healing efforts-properly formatted collagen.

Once a wound occurs, the body immediately attempts to introduce its own structural component, collagen, to the wound site in order to begin the healing process.  Properly configured collagen  plays a significant roles in all phases of wound, provides an optimal environment for vascularization (growth of new blood vessels) and promotes the formation of granulation tissue. The presence of intact collagen also facilitates the actions of  other healing properties inherent in the body, assisting the body to overcome healing inhibitors and allowing the body to heal itself.

Biocore's Kollagen technology is the only technology which delivers the only properly configured collagen directly to the wound. Biocore's SkinTemp and Medifil products maintain collagen in its proper triple helical configuration which aggregates  the skin to preserve its healing properties. The science of Biocore's collagen is explained here.

The significance of this technology is demonstrated in the dramatic field and clinical results achieved with numerous doctors in India and abroad. There is not any other product in the market place which demonstrates such improved and cost effective  outcomes as Biocore's Kollagen product line.

Biocore's story is truly a story of changed lives and healing. The company's Kollagen technology has demonstrated dramatic clinical and field results in wide ranging conditions.  Numerous clinical studies on burn wounds, surgical and traumatic wounds and chronic previously unhealable wounds demonstrate the effectiveness of the company's Kollagen technology. Additionally, market research efforts have resulted in the field application of Kollagen products to over thousands of wounds world-wide providing overwhelming confirmation of clinical demonstrations of efficacy.
 
Physicians have learned that Biocore's product healed all wounds quicker than any competing product. Clinical & Field results also demonstrate the effectiveness of Biocore's Kollagen products in comparison to its competitors.

Kollagen wound treatment is effectively 62% less costly than traditional treatment methods with more than double the healing rate. Utilization of Kollagen demonstrates 95% efficacy. Traditional dressing, on the other hand, demonstrate only 43% efficacy with an average cost of 3 times more than Biocore's product in closing wounds.

"Patch" technologies demonstrate greater efficacy than traditional dressings at significantly greater cost. With average costs ranging from 03 to 30 times more for patch technology treatment of chronic wounds treatment, therefore, will cost approximately 15 times  more than Kollagen for patch technology treatment with a 37% failure rate. By comparison, Kollagen products have a 95% success rate at much less cost.

Clinical and field utilization data demonstrates accelerated healing with Kollagen treatment on traumatic and surgical wounds. A one time application of Kollagen on such wounds demonstrates reduced healing time from an average of 15 days. The result is  a direct cost reduction of 50% over traditional methods of treatment, therefore, we see that use of Biocore's product is not limited to skin wounds of chronic nature. In fact, Biocore's products can be used any time there is a break in the skin.

Now, as Envy International brings this product to India, one realization become clear : no longer will wound patients in India have to suffer or die or lose a limb from a lack of technology. With this product, the future has arrived here in India to liberate us from the ignorance of the past. Chronic wounds can be healed, amputations can be prevented, quality of life can be improved and patient's lives can be saved.